Driving Growth: Market Dynamics, Capital & Ecosystem Expansion

Uncovering Forces Shaping Funding, Talent, And Regional Opportunity In This Market

• 

  Cecily Kovatch

  Managing Director Technology Innovation

  NJEDA

• 

  David Perlin

  CSO/EVP

  Hackensack Meridian Health Center for Discovery and Innovation

• 

  Michael Zwick

  Senior Vice President, Research

  Rutgers University

• 

  Matthew Flath

  Matthew joined Onyx Equities in 2016. He oversees implementation and execution of asset level business plans for the retail and industrial segments of the portfolio. Prior to joining Onyx, Matthew served as Vice President at The Goldstein Group for 8 years, where he facilitated over $78 million in lease transactions, and represented over one million square feet of commercial space throughout the metro-New York market. Matthew graduated from the University of Richmond with a Bachelor of Arts in Economics and Political Science. In addition, he is a member of the International Council of Shopping Centers and IOREBA.

  Onyx Equities

  VP, Asset Management

  Matthew Flath

  VP, Asset Management

  Onyx Equities

• 

  David Wolfe

  Mr. Wolfe is the Managing Partner in the Property Tax Department at Skoloff & Wolfe, PC, where he focuses his practice on representing taxpayers in significant real estate tax appeals and property tax related matters. He has extensive experience in all types of property tax appeals, including hotel, multi-family, retail, office, and industrial properties. Mr. Wolfe frequently counsels clients on the property tax implications of the development, acquisition, and disposition of significant assets. He also counsels clients with respect to property tax exemptions and PILOT agreements. Mr. Wolfe serves on the Board of the National Association of Property Tax Attorneys (NAPTA) and as the Co-Chair of the Real Property Tax Practice Committee of the New Jersey State Bar Association. Mr. Wolfe has been featured or quoted in a wide variety of local and national publications, including Forbes.com, GlobeSt.com, Marketwatch.com, The Washington Post, The Wall Street Journal, Law.com, Law360.com, The New York Law Journal, and Commerce Magazine. Mr. Wolfe has a track record of obtaining significant assessment reductions on behalf of his clients. Examples of those assessment reductions include: • Reduced hotel assessment from $188 million to $131million; • Reduced multi-family assessment from $116 million to $67 million; • Reduced office assessment from $115.5 million to $90million; • Reduced supermarket anchored center from $66.9 million to $46 million; • Reduced nursing home assessment from $36 million to $10.1million; • Reduced big box retail assessment from $21.3 million to $13.4 million; • Reduced office assessment from $27.8 million to $6.5million. Mr. Wolfe began his career as an associate at the law firm of Davis Polk and Wardwell in New York. While at Davis Polk, he focused his practice on regulatory investigations, securities litigation and banking disputes. Mr. Wolfe is a member of the American Bar Association House of Delegates and is the Co-Chair of the ABA’s Diversity & Inclusion 360 Presidential Commission. As a young lawyer, Mr. Wolfe served as the Chair of the ABA Young Lawyers Division, the ABA’s largest entity with more than 130,000 members. Mr. Wolfe received his J.D. from New York University School of Law, and graduated from Cornell University with distinction in all subjects.

  Skoloff & Wolfe

  Partner

  David Wolfe

  Partner

  Skoloff & Wolfe

• 

  Daniel Loughlin

  Daniel Loughlin is the vice chairman for JLL’s New Jersey office markets group. He provides corporate representation for both the acquisition and disposition of commercial real estate and advisory services for strategic planning and site development with an expertise in the pharmaceutical and biotech industries. Experience Dan began his career at JLL in July 2008 due to the merger with The Staubach Company. Prior to joining JLL, Dan was a managing principal of The Staubach Company’s New Jersey corporate services division which he joined in 1998. In 1997, Dan was a principal of Loughlin Stanton, LLC, a commercial real estate firm he co-founded. Notable transactions · Sanofi – 1.2M SF Campus Sale – Bridgewater, NJ · Roche - 1.2M SF R&D Campus Sale – Nutley, NJ · Allergan – 431,500 SF HQ Acquisition – Madison, NJ · Merck – 1.2M SF Campus Sale – Summit, NJ · Mallinckrodt – 150,000 SF HQ Acquisition – Bedminster, NJ · Sanofi – 450,000 SF HQ Acquisition – Bridgewater, NJ · Linde – 115,634 SF HQ Acquisition – Bridgewater, NJ · SJP Properties- 330,00 SF Sale-Jersey City, NJ Education and affiliations Dan is a graduate of Long Island University C.W. Post. He has earned a CoreNet Master of Corporate Real Estate (MCR) accreditation, a professional designation focused on the strategic management of corporate real estate. He is a member of the New Jersey Biotechnology Council and a board member for The Cancer Support Community of central New Jersey. He is a 2011 recipient of JLL’s Champion of Excellence award and 2016 MVP Broker Lead.

  JLL

  Vice Chairman

  Moderator

  Daniel Loughlin

  Vice Chairman

  JLL

Building The Future of Life Sciences: Labs, Infrastructure & Future of Innovation Hubs

Establishing Next-Generation Spaces That Enable Critical Discovery, Partnerships, and Collaboration Work

• 

  Lance Bergstein

  CEO

  Lincoln Equities Group

• 

  Christopher Paladino

  President

  New Brunswick Development Corp.

• 

  Sally Lee

  An architect by training, Sally has a reputation for bringing great creativity, innovation and attention to detail to every project she works on, including some of HDR’s most high-profile education, science, workplace, and mixed-use projects around the globe. In her role as Education & Science leader, she directs and executes regional project leadership, strategic planning and business development efforts to help life science corporations and developers achieve their missions and goals.

  HDR

  Education and Science Principal

  Sally Lee

  Education and Science Principal

  HDR

• 

  Matt Hebert

  Matt Hebert is a project executive and life sciences leader at DPR Construction, specializing in highly complex facilities and multi-phased capital improvement projects. With over 27 years of experience, Matt brings deep expertise in managing technically demanding projects that integrate sophisticated MEP systems, advanced equipment, and critical process piping—the backbone of pharmaceutical, R&D, and clinical research facilities. Having started his career in healthcare construction, Matt saw firsthand the profound impact of scientific discovery and patient care, reinforcing his commitment to building environments that support life-changing work. He understands the uncompromising quality standards these projects demand to protect sensitive research, maintain clean environments, and ensure regulatory compliance. Matt is known for fostering strong early engagement with design teams and leveraging alternative delivery methods such as design-assist and design-build. This collaborative approach streamlines decision-making, enhances constructability, and ensures alignment with clients’ business and scientific goals from concept to completion. As a strategic partner, Matt acts as a crucial bridge between owners, design partners, and trade teams—developing clear execution plans that unite all stakeholders and enable seamless project delivery. A certified NYC DOB Site Safety Manager, he maintains an unwavering commitment to safety and quality throughout every phase. Matt holds a Bachelor of Science degree in Civil Engineering from Bucknell University.

  DPR Construction

  Project Executive

  Matt Hebert

  Project Executive

  DPR Construction

• 

  John Falcone

  John Falcone is a business development manager in the life sciences for Siemens industry, specializing in bridging advanced technologies with real-world laboratory needs. With expertise in engineering, controls, and facility operations, he has supported high-level biosafety projects, guided and complex lab retrofits. Known for his relationship-driven approach and technical insight, John helps organizations strengthen research infrastructure, improve operational safety, and achieve lasting results while fostering collaboration and innovation across the scientific community.

  Siemens

  Life Science Business Development Manager

  John Falcone

  Life Science Business Development Manager

  Siemens

• 

  Bill Hunter

  Bill Hunter is a nationally recognized life sciences real estate executive with 20+ years of experience leading $10.5B in acquisitions and 12M+ SF of leasing and repositioning across every major U.S. R&D cluster, including Boston, the Mid-Atlantic, Research Triangle Park, San Francisco, and San Diego. He has delivered transformative projects with leading pharmaceutical, biotech, academic, and institutional partners nationwide.

  Tourmaline Capital Partners

  President, Tourmaline Life Sciences

  Moderator

  Bill Hunter

  President, Tourmaline Life Sciences

  Tourmaline Capital Partners